Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The present study was carried out on Sprague Dawley rats to evaluate the sub-acute toxicity of an anti - tumor necrosis factor -alpha receptor fusion protein named etanercept. Etanercept is a biopharmaceutical compound and is the first anti-tumor necrosis factor agent to be approved for the treatment of rheumatoid arthritis. |